EGFR and glioma: Additionally, the “ErbB Signaling Pathway,” “Tight Junction,” “Glioma,” and “Small Cell Lung Cancer” pathways are also prominently represented, further highlighting the broad regulatory impact of NFIA, NFIB, NFIC, and NFIX on several types of cancer (Fig. 4, E and F).